RETRACTION: Targeting MYCN IRES in MYCN-amplified Neuroblastoma With Mir-375 Inhibits Tumor Growth and Sensitizes Tumor Cells to Radiation.

IF 6.6 2区 医学 Q1 Biochemistry, Genetics and Molecular Biology Molecular Oncology Pub Date : 2025-01-01 Epub Date: 2024-12-03 DOI:10.1002/1878-0261.13775
{"title":"RETRACTION: Targeting MYCN IRES in MYCN-amplified Neuroblastoma With Mir-375 Inhibits Tumor Growth and Sensitizes Tumor Cells to Radiation.","authors":"","doi":"10.1002/1878-0261.13775","DOIUrl":null,"url":null,"abstract":"<p><strong>Retraction: </strong>H. Zhang, T. Liu, S. Yi, L. Gu, and M. Zhou, \"Targeting MYCN IRES in MYCN-amplified Neuroblastoma With Mir-375 Inhibits Tumor Growth and Sensitizes Tumor Cells to Radiation,\" Molecular Oncology 9, no. 7 (2015): 1301-1311, https://doi.org/10.1016/j.molonc.2015.03.005. The above article, published online on 24 March 2015 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Kevin Ryan; FEBS Press; and John Wiley & Sons Ltd. The retraction has been agreed upon following an investigation into concerns raised by a third party, which revealed inappropriate image section duplications within the article (Figure 5B) and between this (Figures 3B and 4B) and another article published by the same group of authors in a different scientific context. The authors were unable to provide a satisfactory explanation and the original raw data, which has led the editors to lose confidence in the data presented. Therefore, the editors consider the conclusions substantially compromised and are retracting the paper.</p>","PeriodicalId":18764,"journal":{"name":"Molecular Oncology","volume":" ","pages":"261"},"PeriodicalIF":6.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11705729/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/1878-0261.13775","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/3 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

Retraction: H. Zhang, T. Liu, S. Yi, L. Gu, and M. Zhou, "Targeting MYCN IRES in MYCN-amplified Neuroblastoma With Mir-375 Inhibits Tumor Growth and Sensitizes Tumor Cells to Radiation," Molecular Oncology 9, no. 7 (2015): 1301-1311, https://doi.org/10.1016/j.molonc.2015.03.005. The above article, published online on 24 March 2015 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Kevin Ryan; FEBS Press; and John Wiley & Sons Ltd. The retraction has been agreed upon following an investigation into concerns raised by a third party, which revealed inappropriate image section duplications within the article (Figure 5B) and between this (Figures 3B and 4B) and another article published by the same group of authors in a different scientific context. The authors were unable to provide a satisfactory explanation and the original raw data, which has led the editors to lose confidence in the data presented. Therefore, the editors consider the conclusions substantially compromised and are retracting the paper.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
撤回:用Mir-375靶向MYCN IRES在MYCN扩增的神经母细胞瘤中抑制肿瘤生长并使肿瘤细胞对辐射敏感。
引用本文:张宏,刘涛,易淑娟,顾丽,周敏,“靶向MYCN IRES的Mir-375抑制肿瘤生长和肿瘤细胞对辐射的敏感性”,中国生物医学工程学报,第9期。上述文章于2015年3月24日在Wiley online Library (wileyonlinelibrary.com)上发表,经主编Kevin Ryan同意撤回;2月出版社;及约翰威利父子有限公司。在对第三方提出的问题进行调查后,已同意撤回,该第三方发现文章中(图5B)以及这篇文章(图3B和4B)与同一组作者在不同科学背景下发表的另一篇文章之间存在不适当的图像部分重复。作者无法提供令人满意的解释和原始数据,这导致编辑对所提供的数据失去信心。因此,编辑们认为这些结论在很大程度上受到了损害,正在撤回这篇论文。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Molecular Oncology
Molecular Oncology Biochemistry, Genetics and Molecular Biology-Molecular Medicine
CiteScore
11.80
自引率
1.50%
发文量
203
审稿时长
10 weeks
期刊介绍: Molecular Oncology highlights new discoveries, approaches, and technical developments, in basic, clinical and discovery-driven translational cancer research. It publishes research articles, reviews (by invitation only), and timely science policy articles. The journal is now fully Open Access with all articles published over the past 10 years freely available.
期刊最新文献
Addressing persistent challenges in digital image analysis of cancer tissue: resources developed from a hackathon. Classification of acute myeloid leukemia based on multi-omics and prognosis prediction value. Cytokine-centered strategies to boost cancer immunotherapy. Etoposide-induced cancer cell death: roles of mitochondrial VDAC1 and calpain, and resistance mechanisms. Response to neoadjuvant chemotherapy in early breast cancers is associated with epithelial-mesenchymal transition and tumor-infiltrating lymphocytes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1